New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission

Details for Australian Patent Application No. 2005251909 (hide)

Owner A. Carlsson Research AB

Inventors Waters, Nicholas; Sonesson, Clas; Swanson, Lars

Agent Shelston IP

Pub. Number AU-A-2005251909

PCT Pub. Number WO2005/121088

Priority 60/637,530 20.12.04 US; 0403142-3 20.12.04 SE; 0401464-3 08.06.04 SE; 60/577,953 08.06.04 US

Filing date 8 June 2005

Wipo publication date 22 December 2005

International Classifications

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 211/18 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/52 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 295/06 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/14 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2005/121088 Priority application(s): WO2005/121088

9 October 2008 Assignment before Grant

  NeuroSearch Sweden AB The application has been assigned to NSAB, Filial af NeuroSearch Sweden AB, Sverige

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251910-DPP-IV inhibitors

2005251908-New substituted piperidines as modulators of dopamine neurotransmission